Crossmark

Model-Based Meta-Analysis of IL-17 A Inhibitors for Moderate-to-Severe Plaque Psoriasis: Establishing Exposure-Response Relationships to Inform Targeted Drug Development

Crossref DOI link: https://doi.org/10.1007/s12016-025-09123-5

Published Online: 2026-01-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Yixiao

Chen, Xiaoya

Xu, Ling

Zheng, Qingshan

Li, Lujin
Funding

Funding for this research was provided by:

China national key research and development program (2022YFC3502000)

National Key R&D Program of China (SQ2024YFC3500039)

National Natural Science Funds of China (82174229)

Shanghai S&T Innovation Plan (17401970900)
License Information

Text and Data Mining valid from 2026-01-16

Version of Record valid from 2026-01-16
More Information

Article History

Received: 12 August 2025

Accepted: 4 December 2025

First Online: 16 January 2026

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below